• Home
  • Stock
  • Remus Pharmaceuticals Fundamental Analysis
  • Remus Pharmaceuticals Fundamental Analysis

Remus Pharmaceuticals fundamental analysis

REMUS

MiscellaneousSmall

830

15.20 (1.87%)
Last updated on 11 Nov, 2025 | 09:27 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Remus Pharmaceuticals Fundamentals

P/E Ratio

32.68

P/B Ratio

3.63

Div. Yield

0.09

Sector P/E

35.78

Sector P/B

2.58

Sec. Div. Yield

94.22

  • Remus Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 32.68, compared to the sector average of 35.78. Its P/B Ratio stands at 3.63, while the sector’s is 2.58. In terms of returns, the stock offers a Dividend Yield of 0.09%, which is than the sector’s 94.22%.

Remus Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Remus Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.